OncoSTING is developing novel bladder cancer
therapies that work in two ways
Harnessing the potency of
standard BCG immunotherapy
Long-lived delivery of potent
STING agonists using BCG as the
delivery vehicle
STING agonists
Revolutionizing
bladder cancer therapy
OncoSTING is developing novel bladder cancer
Harnessing the potency of
standard BCG immunotherapy
Long-lived delivery of potent
STING agonists using BCG as the
delivery vehicle
